Atlas Trials

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

Clinical trial NCT03073967 · COMPLETED

Trial details

NCT number
NCT03073967
Sponsor
AiCuris Anti-infective Cures AG
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HSV Infection
Start date
2017-05-08
Primary completion
2025-08-15
Enrollment
158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.